KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Gilead Sciences (GILD) Operating Margin (2016 - 2025)

Historic Operating Margin for Gilead Sciences (GILD) over the last 17 years, with Q3 2025 value amounting to 42.82%.

  • Gilead Sciences' Operating Margin rose 310500.0% to 42.82% in Q3 2025 from the same period last year, while for Sep 2025 it was 36.06%, marking a year-over-year increase of 331600.0%. This contributed to the annual value of 5.78% for FY2024, which is 222700.0% down from last year.
  • Gilead Sciences' Operating Margin amounted to 42.82% in Q3 2025, which was up 310500.0% from 34.93% recorded in Q2 2025.
  • Gilead Sciences' Operating Margin's 5-year high stood at 51.77% during Q3 2021, with a 5-year trough of 64.64% in Q1 2024.
  • Over the past 5 years, Gilead Sciences' median Operating Margin value was 32.41% (recorded in 2022), while the average stood at 25.95%.
  • Its Operating Margin has fluctuated over the past 5 years, first crashed by -914800bps in 2024, then soared by 982000bps in 2025.
  • Gilead Sciences' Operating Margin (Quarter) stood at 12.98% in 2021, then soared by 136bps to 30.68% in 2022, then decreased by -26bps to 22.66% in 2023, then surged by 43bps to 32.4% in 2024, then surged by 32bps to 42.82% in 2025.
  • Its Operating Margin stands at 42.82% for Q3 2025, versus 34.93% for Q2 2025 and 33.55% for Q1 2025.